Navigation Links
AFTS Labs Partners With Physicians To Complement NY's Mandated I-STOP Tracking System For Pain Pill Prescriptions: A Recipe For A Safer Community
Date:7/1/2012

(PRWEB) July 01, 2012

The prescription drug abuse problem has skyrocketed in the past decade. According to the Center for Disease Control (CDC), over 20,000 Americans die each year of prescription drug abuse. Opioid pain relievers now account for more overdose deaths than cocaine and heroin combined.

The landmark deal that was announced by Governor Cuomo mandates real-time tracking when doctors write prescriptions for controlled substances and when pharmacists fill them. Prior to this deal, participation was not mandatory, however all physicians must participate in this new tracking system.

AFTS Labs is dedicated to combating this growing drug problem by educating physicians, staff, and community on better prescription drug safety protocols. “Now that physicians are being mandated to track the prescriptions of their pain patients, AFTS Labs is on a quest to help physicians and their practices combat prescription drug abuse. A large part of our business is given back in the form of educating physicians on teaching their staff and patients on safety protocols when it comes to medication monitoring”, said Dr. Richard Stripp, owner and chief toxicologist at AFTS Labs.

AFTS Labs is committed to helping physicians make informed decisions for improved patient care. In the face of current national trends, there are many clinical reasons for incorporating drug testing into routine pain practices:

  •     Provides the clinician with an objective test that documents prescription drug adherence, misuse and/or illicit drug usage.
  •     Identifies drugs that have the potential to cause adverse reactions.
  •     Aids in the diagnosis or treatment of disease or addiction.
  •     Confirms compliance with the agreed upon treatment plan and makes the patient aware that drug testing is an essential part of the treatment plan.
  •     Identifies intentional dilution, adulteration, substitution or tampering of the specimen.
  •     Justifies the continuation of chronic opioid therapy in patients who adhere to the treatment plan and have acceptable drug tests.
  •     Provides rationale to change the treatment plan in patients with unacceptable drug tests and supports referral to addiction specialists.
  •     Identifies the use of medications from other sources that can complicate the treatment plan.
  •     Serves as a resource when doctors are acting as advocates for the patients in family and social issues.
  •     Identifies patient inaccuracies with self-reported medication use.
  •     Foster communication and reinforces trust between physician and patient.
If you are a physician requiring education on safety protocols and medication monitoring, please feel free to contact our laboratory for additional information.

AFTS Labs specializes in providing clinical oral fluid and urine drug testing for the substance abuse, pain management and forensic industries. With our reputation for accuracy and swift turnaround times, AFTS Labs is recognized as the premier facility for reliable results and clinical drug testing services. For more information please visit http://www.aftslabs.com or to become a customer, contact Cristen Cuomo at Ccuomo(at)aftslabs(dot)com or 888-214-8444.

Read the full story at http://www.prweb.com/releases/2012/7/prweb9656629.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved  

Related medicine news :

1. ArticlesOnTap.com Partners With OnlineLPNPrograms.net To Offer Consulting Services
2. GSW Telnet Server for Windows Partners with MobileDemand
3. American Academy of Family Physicians joins AmericanEHR Partners
4. The Biochar Company Partners with Hawaii Biochar Products
5. Candeo Partners with Catholic Church Organization to Release New Sexual Addiction Recovery Program
6. TeetheMe.com Partners with SwaddleDesigns
7. ACP-New York State Chapter partnership results in patient safety organization recognition
8. Cyber exercise partners help you go the distance
9. FDA clears test developed in partnership with VCU researcher
10. Global Cassava Partnership for the 21st Century (GCP21)
11. Partnership provides inclusive workout
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
AFTS Labs Partners With Physicians To Complement NY's Mandated I-STOP Tracking System For Pain Pill Prescriptions: A Recipe For A Safer Community
(Date:7/26/2017)... ... 26, 2017 , ... Evergreen Healthcare Partners is proud to ... to provide innovative offerings to their healthcare partners. These solutions will help Evergreen’s ... teams to address healthcare IT’s biggest challenges. , “Adding Talent Management Solutions to ...
(Date:7/26/2017)... ... July 26, 2017 , ... The ... Process Validation and Process Validation Statistics Conferences in Bethesda, Maryland, 12 – ... challenges faced by process validation professionals and statisticians today. , “These conferences ...
(Date:7/26/2017)... , ... July 26, 2017 , ... “We are thrilled ... the ability for patients to schedule an appointment online in real time,” said Keith ... Six Month Smiles provider directory will bring more Six Month Smiles patients to their ...
(Date:7/26/2017)... ... July 26, 2017 , ... The Amnesty Rally 2017 will be held on ... 3313 Bernstein Park Drive in Monroe (adjacent to the Louisiana Purchase Gardens & Zoo). ... gun violence throughout Monroe. Citizens can turn in unregistered, illegally-held and imitation guns to ...
(Date:7/25/2017)... ... , ... “Now Hiring!” is a popular phrase at Home Delivery Incontinent ... sales for over 30 consecutive years and now plans to hire more than 100 ... excitement and growth at HDIS, following the company’s acquisition by Fortune 1000 company Domtar. ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... 2017 E.I. Medical Imaging (EIMI) has partnered ... custom design the worlds first ultrasound system to be used ... native habitat. In preparation for a piece produced by ... Week, Dr. Guttridge approached EIMI with the idea of an ... hammerhead sharks underwater. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 ... to treat rare nervous system diseases, has concluded a worldwide ... market the drug SOM0226 against transthyretin amyloidosis (ATTR). Before this ... results in a Phase 2 study conducted in ... the United States ...
(Date:7/21/2017)... EDMONTON, Alberta , July 21, 2017 ... the University of Alberta in Edmonton, ... Nature,s partner journal, Schizophrenia 1 , demonstrating that ... of schizophrenia with 74% accuracy. This retrospective analysis ... specific symptoms in schizophrenia patients with significant correlation, ...
Breaking Medicine Technology: